Auger Molecular Therapy (AMT) for Malignant Cutaneous Lesions Treatment

Clinical trial NCT04807257 · RECRUITING

Trial details

NCT number: NCT04807257
Sponsor: NanoRay Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Fungating Wound

Start date: 2024-08-05
Primary completion: 2025-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.